Related Experiment Video

Updated: Jul 4, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Involvement of the TGF-beta and mTOR/p70S6Kinase pathways in the transformation process induced by v-ErbA

S Gonin-Giraud1, C Bresson-Mazet, O Gandrillon

  • 1Université de Lyon, Lyon, France. gonin@cgmc.univ-lyon1.fr

Leukemia Research
|June 25, 2008
PubMed

Insights

The oncogenic v-ErbA protein transforms cells by blocking differentiation and activating the mTOR/p70S6K pathway, conferring TGF-beta independency. This study reveals v-ErbA

Area of Science:

  • Oncogenic signaling
  • Molecular biology
  • Cellular transformation

Background:

  • v-ErbA, the oncogenic form of TRalpha/c-ErbA, blocks erythroid progenitor differentiation.
  • Its oncogenic potential is linked to antagonizing TRalpha/c-ErbA and retinoic acid receptor activity.
  • Cytoplasmic retention of v-ErbA suggests interference with intracellular signaling.

Purpose of the Study:

  • To investigate the role of v-ErbA in modulating intracellular signaling pathways.
  • To determine if v-ErbA confers resistance to TGF-beta.
  • To identify signaling pathways regulated by v-ErbA in erythroid progenitors.

Main Methods:

  • Analysis of v-ErbA's effect on TGF-beta signaling.
  • Investigation of the mTOR/p70S6K pathway activation.
  • Assessment of band3 gene expression in response to TGF-beta and v-ErbA.

Main Results:

  • The transforming v-ErbA confers TGF-beta independency to chicken erythroid progenitors.
  • v-ErbA induces activation of the mTOR/p70S6K pathway.
  • Both TGF-beta and mTOR/p70S6K pathways regulate the expression of the v-ErbA target gene, band3.

Conclusions:

  • v-ErbA modulates specific signaling pathways, including TGF-beta and mTOR/p70S6K.
  • These pathway alterations lead to changes in band3 gene expression, contributing to cellular transformation.
  • This is the first demonstration of v-ErbA's specific modulation of signaling pathways impacting transformation-related gene expression.

More Related Videos

Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...